School-based deworming

Challenges

Collaborations

Commitment

School based deworming

Age (years)

Mea

n no

of

wor

ms

Age-infection profile for STH infections

Benefits of deworming

Long term increases in

productivity over a life time

School Adulthood

Treat at least 75% of at risk children by 2010By 2010, only 1/3 of children requiring treatment were

receiving it.

Improved attendance

Improved performance

Challenges to deworming• Commitment & ownership• Coordination• Resources

– Human– Financial– Antihelminthics

• Accurate reporting • Uptake• Evidence

Sustain, expand and extend drug access programmes to ensure the necessary

supply of drugs and other interventions to help control by 2020 schistosomiasis,

STH, Chagas disease, VL, and onchocerciasis.

Enhance collaboration and coordination on NTDs at national and international levels

through public and private multilateral organisations to work more efficiently and

effectively together

Since 2012, we have seen in an increase in the level of commitment towards controlling STH infections

Sustain, expand and extend drug access programmes to ensure the necessary

supply of drugs and other interventions to help control by 2020 schistosomiasis,

STH, Chagas disease, VL, and onchocerciasis.

Enhance collaboration and coordination on NTDs at national and international levels

through public and private multilateral organisations to work more efficiently and

effectively together

Since 2012, we have seen in an increase in the level of commitment towards controlling STH infections

This Commitment was reiterated and

reinforced at the NTD meeting in Paris in April

Staying Vigilant

2008 2009 2010 2011 201202468

101214

Children dewormed through SF programmes

mill

ion

s

- Change in procurement - Issues in reporting structure:

drugs consumed or drugs delivered?

- Lack of communication between stakeholders at all levels

Numbers being reached through WFP dropped between 2008 and 2012.

Breaks in the supply chain:

Working together to identify the gaps, ensuring intervention sustainability

But… the Pieces are in Place• Strong evidence base• Global advocacy• Donations: 1.12 billion treatments are being donated:

– GSK – 400m tablets of albendazole a year – J&J – 200m tablets of mebendazole– Merck – 250m tablets of PZQ a year

• Commitments from organisations for delivery, research, integration strategies

• Commitments from governments • Serves as the largest coordinated effort to date to

combat NTDs

Linking research with the fieldElimination of Ascaris – what is the breakpoint?

Anderson R et al. Phil. Trans. R. Soc. B 2014

Developing risk maps from prevalence data to inform intervention and MDA programmes

Harnessing existing capacity• Integrate with other activities:

– Other NTD control programmes (eg oncho)– Other delivery mechanisms– Maximise resources

The reach of the WFP

Role of Partnerships

Community, Schools & Teachers

GovernmentNGOs

Donors

International organizations

Challenges do Remain:• Continued commitment• Delivering drugs to those who need them• Coordinating players• Measuring Progress: is it pills consumed

or pills delivered?• Increasing coverage

– Reaching SAC not enrolled and pre-SAC• Sustainability

It is possible….

The case of Bihar state, India

• Included coordination between all partners, mapping, cascaded trainings, community sensitization, monitoring

• Programme implemented from Feb –April 2011• Treated >17 million school-age children for 30

cents/child

PCD

• Implementing evidence based research• Collaborate with:

– Governments– Other NGOs– Academia

• Supporters rather than implementers• Working in Partnership

Find out more @

www.child-development.org

For our latest• Research• Case studies• Toolkitsand views

www.facebook.com/PartnershipforChildDevelopment

@ schoolhealth

Find out more @

www.schoolsandhealth.org

Follow SHN @schoolhealth

For School Health & Nutrition (SHN): • Documents & resources • News & Events• SHN topic information• Country specific data